Host genetic polymorphism analysis in cervical cancer.

BACKGROUND The natural history of cervical cancer comprises a latency period that probably involves long-term immunologic tolerance of human papillomavirus infection. Identifying host determinants of viral persistence may help to better understand the mechanisms of tolerance and may lead to the development of tests that can allow more focused follow-up of high-risk individuals. METHODS Genotypic frequencies of 12 polymorphic loci in four candidate genes from 127 cervical cancer patients were compared with a control group of 108 female blood donors. Genotypes were determined by PCR amplification and direct sequencing of isolated genomic DNA. RESULTS The tumor necrosis factor-alpha (TNFalpha) -238 polymorphism was significantly underrepresented in cervical cancer patients [heterozygotes (HETs), odds ratio (OR) = 0.33; 95% confidence interval (CI), 0.11-0.96], as was the TNFalpha -376 polymorphism (P = 0.02; 0% for any variant genotype in cases vs 4.7% in controls). The NRAMP1 3' untranslated region STP+86 polymorphism also appeared to be inversely associated with cervical cancer, but this result did not reach statistical significance (HET, OR = 0.57; 95% CI, 0.32-1.02). The p53 codon 72 arginine allele showed a suggestive negative association with cervical cancer (HET, OR = 0.49; 95% CI, 0.14-1.63; homozygotes, OR = 0.35; 95% CI, 0.11-1.17). The remaining alleles tested showed no association with cervical cancer. CONCLUSIONS We identified host genetic polymorphisms that may be associated with cervical cancer risk, some of which have been linked to potential functional effects on cellular immune responses or antigen processing. We failed to confirm earlier reports of increased cervical cancer susceptibility in women who harbor the p53 P72R allele. Although our findings support the general hypothesis that host immunogenetic determinants other than class II MHC may be important in the development of cervical cancer, further analysis of the HLA gene cluster comprising the implicated TNFalpha single-nucleotide polymorphisms will be required to determine whether their association is linkage independent.

[1]  A. Kadish.  Biology of anogenital neoplasia. , 2001, Cancer treatment and research.

[2]  D. Kwiatkowski,et al.  Science, medicine, and the future: susceptibility to infection. , 2000, BMJ.

[3]  B. Monk,et al.  Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. , 1997, Journal of the National Cancer Institute.

[4]  M. Schiffman,et al.  Persistence of type-specific human papillomavirus infection among cytologically normal women. , 1994, The Journal of infectious diseases.

[5]  J. Chun,et al.  The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. , 2001, Cancer letters.

[6]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.

[7]  H. Hausen.  Cervical Carcinoma and Human Papillomavirus: On the Road to Preventing a Major Human Cancer , 2001 .

[8]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[9]  B. Taylor,et al.  Genetic regulation of resistance to intracellular pathogens , 1982, Nature.

[10]  H. zur Hausen,et al.  Oncogenic DNA viruses , 2001, Oncogene.

[11]  A. Hill,et al.  The genomics and genetics of human infectious disease susceptibility. , 2001, Annual review of genomics and human genetics.

[12]  N. Kiviat,et al.  HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  T. Agorastos,et al.  p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women. , 2000, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  S. Levine,et al.  Polymorphisms in candidate asthma genes. , 2001, The American journal of the medical sciences.

[15]  D. Kwiatkowski.  Genetic dissection of the molecular pathogenesis of severe infection , 2000, Intensive Care Medicine.

[16]  P. Gros,et al.  Regulation of resistance to leprosy by chromosome 1 locus in the mouse , 2004, Immunogenetics.

[17]  M. Schiffman,et al.  Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial. , 2001, Journal of the National Cancer Institute.

[18]  G. Bai,et al.  3'UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. , 2000, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[19]  F. Montz,et al.  HPV testing: where are we now? , 2000, Anticancer research.

[20]  T. Rohan,et al.  Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. , 2001, JAMA.

[21]  C. Woodman,et al.  Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study , 2001, The Lancet.

[22]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[23]  I. Jacobs,et al.  p53 codon 72 polymorphism and risk of cervical cancer in UK , 1998, The Lancet.

[24]  Ranajit Chakraborty,et al.  p53 codon 72 polymorphism and risk of cervical cancer. , 2003, Biological research.

[25]  H. Whittle,et al.  Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. , 1998, The New England journal of medicine.

[26]  G. Gerken,et al.  Tumor necrosis factor alpha promoter polymorphism at position ‐238 is associated with chronic active hepatitis C infection , 1998, Journal of medical virology.

[27]  T. Kwan,et al.  Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression , 1994, The Journal of experimental medicine.

[28]  P. Gros,et al.  The Nramp1 protein and its role in resistance to infection and macrophage function. , 1999, Proceedings of the Association of American Physicians.

[29]  S. Grinstein,et al.  Natural Resistance to Intracellular Infections: Natural Resistance–Associated Macrophage Protein 1 (Nramp1) Functions as a Ph-Dependent Manganese Transporter at the Phagosomal Membrane , 2000 .

[30]  D. Bradley.  Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection. , 1977, Clinical and experimental immunology.

[31]  A. Hill.  Immunogenetics and genomics , 2001, The Lancet.

[32]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[33]  D. Persing,et al.  Cervical cancer in older women: a molecular analysis of human papillomavirus types, HLA types, and p53 mutations. , 1998, American journal of obstetrics and gynecology.

[34]  G. Rui.  Influence of TNF-α gene polymorphisms on TNF-α production and disease , 2003 .

[35]  C. Greenwood,et al.  Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. , 2000, American journal of human genetics.

[36]  T. Chatila,et al.  The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. , 1997, The New England journal of medicine.

[37]  M. Carrington,et al.  Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. , 2001, The Journal of infectious diseases.

[38]  R. Marks,et al.  Squamous cell carcinoma , 1996, The Lancet.

[39]  A. Hajeer,et al.  Influence of TNFa gene polymorphisms on TNFa production and disease , 2001 .

[40]  G. Voglino,et al.  Codon 72 polymorphism of p53 and its association with cervical cancer , 1999, The Lancet.

[41]  P. Gros,et al.  Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. , 1981, Journal of immunology.

[42]  M. Stoler.  HPV for Cervical Cancer Screening , 2001, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[43]  D. Kwiatkowski,et al.  Severe malarial anemia and cerebral malaria are associated with different tumor necrosis factor promoter alleles. , 1999, The Journal of infectious diseases.

[44]  D M Parkin,et al.  International trends in incidence of cervical cancer: II. Squamous‐cell carcinoma , 2000, International journal of cancer.

[45]  A. Moscicki,et al.  Th1 Cytokine Patterns in Cervical Human Papillomavirus Infection , 1999, Clinical Diagnostic Laboratory Immunology.

[46]  Y. Yaginuma,et al.  Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix. , 1999, Carcinogenesis.

[47]  J. Cuzick,et al.  Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women , 2000, British Journal of Cancer.

[48]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[49]  E. Franco,et al.  p53 polymorphism in codon 72 and risk of human papillomavirus‐induced cervical cancer: effect of inter‐laboratory variation , 2000, International journal of cancer.

[50]  D. Spandidos,et al.  P53 codon 72 polymorphism as a risk factor in the development of HPV-associated cervical cancer. , 2000, Molecular cell biology research communications : MCBRC.

[51]  F. Wiklund,et al.  Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. , 2001, Human immunology.

[52]  Schneider,et al.  A tumour necrosis factor‐alpha (TNF‐α) promoter polymorphism is associated with chronic hepatitis B infection , 1998 .

[53]  Irene M. Leigh,et al.  Role of a p53 polymorphism in the development of human papilloma-virus-associated cancer , 1998, Nature.

[54]  M. von Knebel Doeberitz,et al.  No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer , 1999, Journal of Molecular Medicine.

[55]  P. Gros,et al.  Natural Resistance to Infection with Intracellular Pathogens: The Nramp1 Protein Is Recruited to the Membrane of the Phagosome , 1997, The Journal of experimental medicine.

[56]  A. Glynn,et al.  Genetics of resistance to infection with Salmonella typhimurium in mice. , 1976, The Journal of infectious diseases.

[57]  T. Huizinga,et al.  Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. , 2001, Cytokine.